1. Home
  2. LWLG vs RCEL Comparison

LWLG vs RCEL Comparison

Compare LWLG & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightwave Logic Inc.

LWLG

Lightwave Logic Inc.

HOLD

Current Price

$14.83

Market Cap

2.5B

Sector

Industrials

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.22

Market Cap

171.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LWLG
RCEL
Founded
1991
N/A
Country
United States
United States
Employees
N/A
226
Industry
Containers/Packaging
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
171.5M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
LWLG
RCEL
Price
$14.83
$4.22
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.88
AVG Volume (30 Days)
9.7M
200.7K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
15.79
N/A
EPS
N/A
N/A
Revenue
$236,855.00
N/A
Revenue This Year
N/A
$17.17
Revenue Next Year
N/A
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
147.74
N/A
52 Week Low
$0.92
$3.22
52 Week High
$18.28
$7.65

Technical Indicators

Market Signals
Indicator
LWLG
RCEL
Relative Strength Index (RSI) 61.52 45.00
Support Level $3.19 $4.02
Resistance Level N/A $4.57
Average True Range (ATR) 2.05 0.27
MACD 0.06 -0.05
Stochastic Oscillator 56.26 9.43

Price Performance

Historical Comparison
LWLG
RCEL

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: